Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 7
2008 12
2009 9
2010 7
2011 12
2012 27
2013 16
2014 23
2015 17
2016 21
2017 32
2018 19
2019 26
2020 29
2021 41
2022 30
2023 31
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean seung hyeon han (3 results)?
Plasma Levels of Polyunsaturated Fatty Acids and Adverse Kidney Outcomes.
Koh HB, Kim HW, Joo YS, Jung CY, Kim HJ, Chang TI, Park JT, Yoo TH, Kang SW, Han SH. Koh HB, et al. Among authors: han sh. Am J Kidney Dis. 2024 Feb 28:S0272-6386(24)00622-X. doi: 10.1053/j.ajkd.2023.12.020. Online ahead of print. Am J Kidney Dis. 2024. PMID: 38423161
Findings from the KNOW-CKD Study indicate that higher systolic blood pressure time in target range is associated with a lower risk of chronic kidney disease progression.
Park CH, Kim HW, Joo YS, Park JT, Chang TI, Yoo TH, Park SK, Kim YH, Sung S, Hyun YY, Oh KH, Kang SW, Han SH; KNOW-CKD (KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease) Investigators. Park CH, et al. Among authors: han sh. Kidney Int. 2024 Apr;105(4):835-843. doi: 10.1016/j.kint.2023.12.008. Epub 2023 Dec 28. Kidney Int. 2024. PMID: 38159679
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
326 results